Menu

Recent Interviews

Jerre Foo, Corporate Development Executive, Silkroad Nickel

Jerre Foo
Corporate Development Executive | Silkroad Nickel
50 Armenian Street #03-04, 179938 Singapore (SGP)

enquiries@silkroadnickel.com

+65 6327 8971

Silkroad Nickel: 'The course is set for dynamic profit growth.'


Dr. Thomas Gutschlag, CEO, Deutsche Rohstoff AG

Dr. Thomas Gutschlag
CEO | Deutsche Rohstoff AG
Q7, 24, 68161 Mannheim (D)

info@rohstoff.de

+49 621 490 817 0

Interview Deutsche Rohstoff AG: "We can imagine additional investments in the field of electromobility."


Steve Cope, President, CEO and Director, Silver Viper

Steve Cope
President, CEO and Director | Silver Viper
1055 W Hastings St Suite 1130, V6E 2E9 Vancouver (CAN)

info@silverviperminerals.com

+1-604-687-8566

Interview with Silver Viper: Future price drivers and takeover fantasy


23. September 2020 | 14:13 CET

Deutsche Bank, Daimler, Triumph Gold: What about these fallen angels?

  • Investments
Photo credits: pixabay.com

When investigative journalists immerse themselves in the world of business, the name of Deutsche Bank is mentioned more and more often. Despite countless legal disputes and fines in recent years, the news flow does not end, the latest accusations being activities that observers call money laundering. The documentation surrounding the business relationship between Donald Trump and Deutsche Bank has cast what was once the world's largest financial institution, in a bad light. Although Trump had owed money to one department of the bank for a long time, another department of the bank lent money to the then dazzling real estate mogul to pay off his debts. Many investors would certainly not have thought that such a transaction, based on the principle of right pocket to left pocket would be possible at all. Deutsche Bank rejected a comment on the above-mentioned incident concerning banking secrecy.

time to read: 2 minutes by Nico Popp


 

Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author


The long case of Deutsche Bank

However, the recent history of Deutsche Bank is not well received on the stock market. In the last five days alone, the share price has lost more than 9%. On a one-year horizon, the loss is 2%. That does not sound much, but over the last five years the share price has already fallen by almost 70%.

Apart from legal disputes, low-interest rates are the main burden on the banking business. After the aweful year 2019, the bank wanted to return to profitability for the first time in 2020. But the pandemic is likely to thwart these plans. Given the weak starting position for the banking sector in general and the many construction sites for Deutsche Bank in particular, the share is currently of little interest.

Lawsuits against Daimler

Daimler is also regarded as rather uninteresting for investors. The drive revolution in the automotive sector is particularly affecting German premium brands. On a one-year horizon, the share lost about 8%. High costs are still a burden on the group. Nevertheless, after the slump in March, the share price was able to increase significantly and still generate a return of 18.3% on a three-month horizon.

But dark clouds have recently been gathering over Sindelfingen as well: In connection with the diesel affair, investors have filed a million-euro lawsuit against Daimler and are demanding EUR 250 million in damages. Other lawsuits involve smaller amounts. Although Daimler has a substantial financial cushion, lawsuits always create a bad mood. But investors have every reason to look ahead. The company recently announced the truck division is set to take off, climate-neutrally, thanks to electric and hydrogen.

Newmont Mining as a shareholder

The shareholders of Triumph Gold also have a plan in mind. On a one-year horizon, however, the share price is expected to post losses of 34%. The company is searching for gold in the Canadian Yukon region and was able to secure fresh capital in the summer. In the coming months, the flagship project, Freegold Mountain, will be further explored. To date, 39,000 metres have been drilled and approximately two million ounces of gold-equivalent 43-101 mining grade rock have been identified as resources. Thanks to the recent capital injection, the company is now funded through 2021.

While companies such as Deutsche Bank and Daimler are suffering from the general weakness of their industry in addition to their own misconduct, Triumph Gold sees itself supported by the emerging gold boom. The company is considered a promising gold explorer and already has some prominent shareholders. Amongst others, raw material producer Newmont Mining holds a 12.8% stake in Triumph. Newmont operates in the neighbourhood and could be a potential buyer if the upcoming drill results turn out successfully.

The Market ignores ambitious plans

With a market capitalization of around EUR 25 million, a takeover would be easy to achieve, both for Newmont and for many other medium and large gold producers. But this is not yet the case. Triumph initially plans to evaluate existing data to be able to search for new deposits in an even more targeted manner. In the long term, the company is talking about developing a mine itself.

However, there is still a long way to go until then. So far, the market has hardly priced fantasy into Triumph's share price. Given the upcoming drilling and the positive environment for gold in general, Triumph Gold's share could be more promising than that of the other fallen angels.


Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

20. April 2021 | 09:45 CET | by Stefan Feulner

Varta, Sierra Growth, CureVac - Clear signals!

  • Investments

Sometimes, for various reasons, it takes longer before the positive developments of a Company are absorbed by the market and thus provide for price gains. It is currently similar to the precious metal gold, which is still in the consolidation phase. The facts such as national debt, inflation fears and the ultra-loose monetary policy of the central banks speak another clear language.

Read

20. April 2021 | 07:10 CET | by Carsten Mainitz

BioNTech, SunMirror, Steinhoff - Great News!

  • Investments

Shortly before the finish line, the going gets tough again. Many athletes and those who have to really "bite" in the last few meters before a deadline are probably familiar with this feeling. Everyday life in the Corona pandemic is also becoming more exhausting. Now, with BioNTech's announcement that it will double weekly vaccine dose deliveries to around 5.1 million units from the end of May, there may be a breakthrough in achieving herd immunity in Germany in the next few months. It is not only good news for the Company's shareholders but everyone. Below we present two other companies whose shareholders should be very pleased. Let us surprise you!

Read

15. April 2021 | 07:15 CET | by Stefan Feulner

Alibaba, The Place Holdings, CureVac - Great opportunities lie here!

  • Investments

The German vaccination disaster is going into the next round. After the AstraZeneca vaccine's back and forth and the question of whether only younger people, older people or no one should be vaccinated with the vaccine, the American vaccine manufacturer Johnson & Johnson is now experiencing delivery stoppages. The return to "normality" once again seems to be a long way off. Another question to ask yourself. What will future life in the new normal look like in the hard-pressed inner cities?

Read